Chemotherapy: Target Therapy and Immunotherapy:@0.423628:0.035749:0.914577:0.035749:0.914577:0.019993:0.423628:0.019993:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.007177:0.013143:0.005809:0.012950:0.012508:0.006523:0.005330:0.008197:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013143:0.011738:0.013181:0.005330:0.004349:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
11:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
ANAEMIA AND THROMBOCYTOPAENIA:@0.084242:0.096122:0.473367:0.096122:0.473367:0.078306:0.084242:0.078306:0.015608:0.015608:0.015608:0.010904:0.019029:0.005773:0.015608:0.005773:0.015608:0.015608:0.014753:0.005773:0.008766:0.014325:0.012187:0.017746:0.019029:0.012187:0.017746:0.016463:0.013042:0.008766:0.017746:0.011759:0.015608:0.010904:0.015608:0.005773:0.015822
A combination of factors may contribute :@0.084242:0.113632:0.480505:0.113632:0.480505:0.097876:0.084242:0.097876:0.014239:0.007204:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007216:0.012604:0.006042:0.007206:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.007202:0.018049:0.013143:0.010314:0.007216:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.012508:0.005330
to anaemia in cancer patients.  These fac-:@0.084242:0.129997:0.475161:0.129997:0.475161:0.114241:0.084242:0.114241:0.006523:0.012604:0.004560:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.004560:0.003848:0.011738:0.004560:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.004560:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.004560:0.004560:0.008197:0.011738:0.012508:0.007466:0.012508:0.004551:0.006042:0.013143:0.012450:0.006388
tors include myelosuppressive chemother-:@0.084242:0.146361:0.475152:0.146361:0.475152:0.130605:0.084242:0.130605:0.006523:0.012604:0.005792:0.007466:0.005349:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005349:0.018049:0.010314:0.012508:0.003848:0.012604:0.007466:0.011699:0.013123:0.013123:0.005721:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.005349:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005786:0.006388
apy, and possible cancer-related causes :@0.084242:0.162726:0.480474:0.162726:0.480474:0.146970:0.084242:0.146970:0.013143:0.013123:0.010314:0.005330:0.007582:0.013143:0.011738:0.013181:0.007582:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.007582:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006388:0.005707:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.007582:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.005330
such  as haemolysis, bleeding,  renal  dys-:@0.084242:0.179090:0.475152:0.179090:0.475152:0.163334:0.084242:0.163334:0.007466:0.011699:0.012450:0.011738:0.005330:0.004124:0.013143:0.007466:0.009467:0.011738:0.013143:0.012508:0.018049:0.012604:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330:0.009467:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.005330:0.005330:0.004124:0.005713:0.012508:0.011738:0.013143:0.003848:0.005330:0.004127:0.013181:0.010314:0.007466:0.006388
function,  iron  deficiency  or  anaemia  of :@0.084242:0.195454:0.480486:0.195454:0.480486:0.179699:0.084242:0.179699:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.005473:0.003848:0.005717:0.012604:0.011738:0.005330:0.005478:0.013181:0.012508:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.012450:0.010314:0.005330:0.005484:0.012604:0.005792:0.005330:0.005476:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005492:0.012604:0.006042:0.005330
chronic disease.  Treatments  to  mitigate :@0.084242:0.211819:0.480490:0.211819:0.480490:0.196063:0.084242:0.196063:0.012450:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.011661:0.013181:0.003848:0.007466:0.012508:0.013143:0.007478:0.012508:0.005330:0.005330:0.006321:0.007620:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330:0.006319:0.006523:0.012604:0.005330:0.006319:0.018049:0.003848:0.006523:0.003848:0.012950:0.013143:0.006523:0.012508:0.005330
anaemia include iron supplements, blood :@0.084242:0.228183:0.480463:0.228183:0.480463:0.212427:0.084242:0.212427:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005850:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005850:0.003848:0.005715:0.012604:0.011738:0.005850:0.007466:0.011699:0.013123:0.013123:0.003848:0.012508:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330:0.005850:0.013123:0.003848:0.012604:0.012604:0.013181:0.005330
transfusions, erythropoietin.:@0.084242:0.244548:0.335125:0.244548:0.335125:0.228792:0.084242:0.228792:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.007466:0.005330:0.005330:0.012508:0.005792:0.010314:0.006523:0.011738:0.005696:0.012604:0.013123:0.012604:0.003848:0.012508:0.006523:0.003848:0.011738:0.005330
23:@0.335117:0.238925:0.347547:0.238925:0.347547:0.229740:0.335117:0.229740:0.006215:0.006215
Chemotherapy  can  cause  thrombocy-:@0.102424:0.260908:0.475157:0.260908:0.475157:0.245152:0.102424:0.245152:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.002977:0.012450:0.013143:0.011738:0.005330:0.002990:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330:0.002992:0.006523:0.011738:0.005711:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006388
topaenia, which can lead to easy bruis-:@0.084240:0.277273:0.475150:0.277273:0.475150:0.261517:0.084240:0.261517:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.008717:0.015990:0.011738:0.003848:0.012450:0.011738:0.008717:0.012450:0.013143:0.011738:0.008717:0.003848:0.012508:0.013143:0.013181:0.008717:0.006523:0.012604:0.008717:0.012508:0.013143:0.007466:0.010314:0.008717:0.013123:0.005792:0.011699:0.003848:0.007466:0.006388
ing  and  bleeding.  Extremely  low  platelet :@0.084240:0.293637:0.480472:0.293637:0.480472:0.277881:0.084240:0.277881:0.003848:0.011738:0.012950:0.005330:0.003027:0.013143:0.011738:0.013181:0.005330:0.003029:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.005330:0.005330:0.003023:0.010314:0.009236:0.006523:0.005713:0.012508:0.018049:0.012508:0.003848:0.010314:0.005330:0.003031:0.003848:0.012604:0.015990:0.005330:0.003029:0.013123:0.003848:0.013143:0.006523:0.012508:0.003848:0.012508:0.006523:0.005330
counts may require platelet transfusions.  :@0.084240:0.310002:0.480481:0.310001:0.480481:0.294245:0.084240:0.294246:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.006617:0.018049:0.013143:0.010314:0.006639:0.005711:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.006625:0.013123:0.003848:0.013143:0.006523:0.012508:0.003848:0.012508:0.006523:0.006629:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.007466:0.005330:0.012422:0.551401
24:@0.462717:0.304381:0.475147:0.304381:0.475147:0.295196:0.462717:0.295196:0.006215:0.006215
Chemotherapy  treatments may be de-:@0.084242:0.326365:0.475153:0.326365:0.475153:0.310609:0.084242:0.310609:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.006490:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.011834:0.018049:0.013143:0.010314:0.011834:0.013123:0.012508:0.011834:0.013181:0.012508:0.006388
layed to allow platelet counts to recover.:@0.084242:0.342729:0.467533:0.342729:0.467533:0.326974:0.084242:0.326974:0.003848:0.013143:0.010314:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330:0.013143:0.003848:0.003848:0.012604:0.015990:0.005330:0.013123:0.003848:0.013143:0.006523:0.012508:0.003848:0.012508:0.006523:0.005330:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005330:0.006523:0.012604:0.005330:0.005692:0.012508:0.012450:0.012604:0.010660:0.012508:0.004374:0.005330
CHEMOTHERAPY-INDUCED NAUSEA :@0.084242:0.375780:0.449420:0.375780:0.449420:0.357965:0.084242:0.357965:0.016677:0.014539:0.011118:0.019242:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256:0.008980:0.005987:0.015822:0.014966:0.013683:0.016677:0.011118:0.014966:0.005987:0.015822:0.015822:0.013683:0.011118:0.011118:0.015822:0.005987
AND VOMITING:@0.084242:0.393610:0.243741:0.393610:0.243741:0.375795:0.084242:0.375795:0.015822:0.015822:0.014966:0.005987:0.014966:0.017960:0.019242:0.005987:0.008980:0.005987:0.015822:0.017960
Chemotherapy-induced nausea and vom-:@0.084242:0.411125:0.475152:0.411125:0.475152:0.395369:0.084242:0.395369:0.015452:0.011545:0.012315:0.017857:0.012411:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.006196:0.003656:0.011545:0.012989:0.011507:0.012257:0.012315:0.012989:0.004378:0.011545:0.012950:0.011507:0.007274:0.012315:0.012950:0.004387:0.012950:0.011545:0.012989:0.004378:0.010468:0.012411:0.017645:0.006388
iting (CINV) are the most feared anti-cancer :@0.084242:0.427489:0.480472:0.427489:0.480472:0.411733:0.084242:0.411733:0.003464:0.006138:0.003464:0.011353:0.012565:0.004118:0.006716:0.015259:0.003964:0.013855:0.013123:0.006716:0.004118:0.012758:0.005328:0.012123:0.004118:0.006138:0.011353:0.012123:0.004118:0.017665:0.012219:0.007081:0.006138:0.004118:0.005657:0.012123:0.012758:0.005328:0.012123:0.012796:0.004118:0.012758:0.011353:0.006138:0.003464:0.006004:0.012065:0.012758:0.011353:0.012065:0.012123:0.005786:0.005330
treatment-related side effects. CINV is com-:@0.084242:0.443854:0.475185:0.443854:0.475185:0.428098:0.084242:0.428098:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.006004:0.005328:0.012123:0.003464:0.012758:0.006138:0.012123:0.012796:0.004811:0.007081:0.003464:0.012796:0.012123:0.004811:0.012123:0.005713:0.005657:0.012123:0.012065:0.006138:0.007081:0.004945:0.004811:0.015259:0.003964:0.013855:0.013123:0.004811:0.003464:0.007081:0.004811:0.012065:0.012219:0.017665:0.006388
mon with many treatments, including plat-:@0.084242:0.460218:0.475160:0.460218:0.475160:0.444462:0.084242:0.444462:0.017665:0.012219:0.011353:0.007262:0.015606:0.003464:0.006138:0.011353:0.007260:0.017665:0.012758:0.011353:0.009929:0.007260:0.006138:0.005326:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.007081:0.004945:0.007260:0.003464:0.011353:0.012065:0.003464:0.011315:0.012796:0.003464:0.011353:0.012565:0.007260:0.012738:0.003464:0.012758:0.006138:0.006388
inum-based regimens (both cisplatin and :@0.084242:0.476582:0.480499:0.476582:0.480499:0.460827:0.084242:0.460827:0.003464:0.011353:0.011315:0.017665:0.006004:0.012738:0.012758:0.007081:0.012123:0.012796:0.010737:0.005328:0.012123:0.012565:0.003464:0.017665:0.012123:0.011353:0.007081:0.010737:0.006716:0.012738:0.012219:0.006138:0.011353:0.010737:0.012065:0.003464:0.007081:0.012738:0.003464:0.012758:0.006138:0.003464:0.011353:0.010737:0.012758:0.011353:0.013181:0.005330
carboplatin). An additional group at risk is :@0.084242:0.492947:0.480465:0.492947:0.480465:0.477191:0.084242:0.477191:0.012065:0.012758:0.005407:0.012738:0.012219:0.012738:0.003464:0.012758:0.006138:0.003464:0.011353:0.006716:0.004945:0.008082:0.013855:0.011353:0.008082:0.012758:0.012796:0.012796:0.003464:0.006138:0.003464:0.012219:0.011353:0.012758:0.003464:0.008082:0.012565:0.005328:0.012219:0.011315:0.012738:0.008082:0.012758:0.006138:0.008082:0.005407:0.003464:0.007081:0.009275:0.008082:0.003464:0.007470:0.005330
young women with breast cancer receiving :@0.084242:0.509311:0.480499:0.509311:0.480499:0.493555:0.084242:0.493555:0.009929:0.012219:0.011315:0.011353:0.012565:0.004587:0.015606:0.012219:0.017665:0.012123:0.011353:0.004589:0.015606:0.003464:0.006138:0.011353:0.004587:0.012738:0.005328:0.012123:0.012758:0.007081:0.006138:0.004589:0.012065:0.012758:0.011353:0.012065:0.012123:0.005407:0.004589:0.005326:0.012123:0.012065:0.012123:0.003464:0.010275:0.003464:0.011353:0.012948:0.005330
combination chemotherapy with doxoru-:@0.084242:0.525676:0.475190:0.525676:0.475190:0.509920:0.084242:0.509920:0.012065:0.012219:0.017665:0.012738:0.003464:0.011353:0.012758:0.006138:0.003464:0.012219:0.011353:0.011295:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.011295:0.015606:0.003464:0.006138:0.011353:0.011295:0.012796:0.012219:0.008852:0.012219:0.005407:0.011315:0.006388
bicin- and cyclophosphamide (AC)-based :@0.084242:0.542040:0.480451:0.542040:0.480451:0.526284:0.084242:0.526284:0.012740:0.003467:0.012065:0.003467:0.011349:0.006006:0.005677:0.012950:0.011545:0.012989:0.005677:0.012257:0.010122:0.012257:0.003656:0.012411:0.012931:0.011545:0.012411:0.007274:0.012931:0.011545:0.012950:0.017857:0.003656:0.012989:0.012315:0.005677:0.006908:0.014047:0.015452:0.006908:0.006196:0.012931:0.012950:0.007274:0.012315:0.013181:0.005330
treatment. Several novel classes of anti-:@0.084242:0.558405:0.475129:0.558405:0.475129:0.542649:0.084242:0.542649:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005138:0.011007:0.009390:0.012315:0.010468:0.012315:0.005600:0.012950:0.003656:0.011007:0.011545:0.012411:0.010468:0.012315:0.003656:0.011007:0.012257:0.003656:0.012950:0.007274:0.007274:0.012315:0.007274:0.011007:0.012411:0.005850:0.011007:0.012950:0.011545:0.006331:0.003656:0.006388
emetics have been developed, helping to :@0.084242:0.574769:0.480488:0.574769:0.480488:0.559013:0.084242:0.559013:0.012315:0.017857:0.012315:0.006331:0.003656:0.012257:0.007274:0.005532:0.011545:0.012950:0.010468:0.012315:0.005532:0.012931:0.012315:0.012315:0.011545:0.005532:0.012989:0.012315:0.010468:0.012315:0.003656:0.012411:0.012931:0.012315:0.012989:0.005138:0.005532:0.011545:0.012315:0.003656:0.012931:0.003656:0.011545:0.012758:0.005532:0.006331:0.012600:0.005330
manage these symptoms successfully in a :@0.084242:0.591134:0.480486:0.591134:0.480486:0.575378:0.084242:0.575378:0.017857:0.012950:0.011545:0.012950:0.012758:0.012315:0.007081:0.006331:0.011545:0.012315:0.007274:0.012315:0.007081:0.007274:0.010122:0.017857:0.012931:0.006331:0.012411:0.017857:0.007274:0.007081:0.007274:0.011507:0.012257:0.012257:0.012315:0.007274:0.007274:0.005850:0.011507:0.003656:0.003656:0.010122:0.007081:0.003656:0.011545:0.007081:0.013146:0.005330
significant  portion  of  patients.  Traditional :@0.084242:0.607498:0.480499:0.607498:0.480499:0.591742:0.084242:0.591742:0.007274:0.003656:0.012758:0.011545:0.003656:0.004589:0.004589:0.012257:0.012950:0.011545:0.006331:0.005330:0.005867:0.012931:0.012411:0.005600:0.006331:0.003656:0.012411:0.011545:0.005330:0.005867:0.012411:0.005850:0.005330:0.005869:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005138:0.005330:0.005867:0.007428:0.005600:0.012950:0.012989:0.003656:0.006331:0.003656:0.012411:0.011545:0.012950:0.003852:0.005330
regimens to prevent CINV involved a com-:@0.084242:0.623863:0.475167:0.623863:0.475167:0.608107:0.084242:0.608107:0.005521:0.012315:0.012758:0.003656:0.017857:0.012315:0.011545:0.007274:0.005195:0.006331:0.012411:0.005195:0.012931:0.005521:0.012315:0.010468:0.012315:0.011545:0.006331:0.005195:0.015452:0.004156:0.014047:0.013316:0.005195:0.003656:0.011545:0.010468:0.012411:0.003656:0.010468:0.012315:0.012989:0.005195:0.012950:0.005195:0.012257:0.012411:0.017857:0.006388
bination of a corticosteroid plus a 5-hydrox-:@0.084242:0.640227:0.475154:0.640227:0.475154:0.624471:0.084242:0.624471:0.012931:0.003656:0.011545:0.012950:0.006331:0.003656:0.012411:0.011545:0.004376:0.012411:0.005850:0.004376:0.012950:0.004376:0.012257:0.012411:0.005600:0.006331:0.003656:0.012257:0.012411:0.007274:0.006331:0.012315:0.005521:0.012411:0.003656:0.012989:0.004376:0.012931:0.003656:0.011507:0.007274:0.004376:0.012950:0.004376:0.010468:0.006196:0.011545:0.010122:0.012989:0.005519:0.012411:0.009044:0.006388
ytryptamine receptor antagonist (5HT3-RA) :@0.084242:0.656592:0.480501:0.656592:0.480501:0.640836:0.084242:0.640836:0.010122:0.006331:0.005600:0.010122:0.012931:0.006331:0.012950:0.017857:0.003656:0.011545:0.012315:0.005369:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.005369:0.012950:0.011545:0.006331:0.012950:0.012758:0.012411:0.011545:0.003656:0.007274:0.006331:0.005369:0.006908:0.010468:0.012950:0.008005:0.010468:0.006196:0.011488:0.014047:0.007102:0.005330
and a neurokinin-1 receptor antagonist :@0.084242:0.672956:0.480495:0.672956:0.480495:0.657200:0.084242:0.657200:0.012950:0.011545:0.012989:0.013258:0.012950:0.013258:0.011545:0.012315:0.011507:0.005521:0.012411:0.009467:0.003656:0.011545:0.003656:0.011545:0.006196:0.010468:0.013258:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.013258:0.012950:0.011545:0.006331:0.012950:0.012758:0.012411:0.011545:0.003656:0.007274:0.006521:0.005330
(NK1-RA). These agents include ondan-:@0.084242:0.689321:0.475190:0.689321:0.475190:0.673565:0.084242:0.673565:0.006908:0.014047:0.011180:0.010468:0.006196:0.011488:0.014047:0.006908:0.005138:0.013547:0.008005:0.011545:0.012315:0.007274:0.012315:0.013547:0.012950:0.012758:0.012315:0.011545:0.006331:0.007274:0.013547:0.003656:0.011545:0.012257:0.003656:0.011507:0.012989:0.012315:0.013547:0.012411:0.011545:0.012989:0.012950:0.011545:0.006388
setron and granisetron (5HT3-RA) and :@0.084242:0.705685:0.480515:0.705685:0.480515:0.689929:0.084242:0.689929:0.007274:0.012315:0.006331:0.005521:0.012411:0.011545:0.017761:0.012950:0.011545:0.012989:0.017761:0.012758:0.005600:0.012950:0.011545:0.003656:0.007274:0.012315:0.006331:0.005519:0.012411:0.011545:0.017761:0.006908:0.010468:0.012950:0.008005:0.010468:0.006196:0.011488:0.014047:0.006908:0.017761:0.012950:0.011545:0.013181:0.005330
aprepitant and fosaprepitant (NK1-RA).  :@0.084242:0.722050:0.480492:0.722050:0.480492:0.706294:0.084242:0.706294:0.012950:0.012931:0.005521:0.012315:0.012931:0.003656:0.006331:0.012950:0.011545:0.006331:0.015471:0.012950:0.011545:0.012989:0.015471:0.005850:0.012411:0.007274:0.012950:0.012931:0.005519:0.012315:0.012931:0.003656:0.006331:0.012950:0.011545:0.006331:0.015471:0.006908:0.014047:0.011180:0.010468:0.006196:0.011488:0.014047:0.006908:0.005326:0.000000:0.005330
Successful  treatment  of  these  unpleasant :@0.084242:0.738414:0.480494:0.738414:0.480494:0.722658:0.084242:0.722658:0.009390:0.011507:0.012257:0.012257:0.012315:0.007274:0.007274:0.005850:0.011507:0.003656:0.005330:0.003394:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005330:0.003396:0.012411:0.005850:0.005330:0.003394:0.006331:0.011545:0.012315:0.007274:0.012315:0.005330:0.003396:0.011507:0.011545:0.012931:0.003656:0.012315:0.012950:0.007274:0.012950:0.011545:0.006521:0.005330
and sometimes crippling symptoms results :@0.084242:0.754779:0.480480:0.754779:0.480480:0.739023:0.084242:0.739023:0.012950:0.011545:0.012989:0.007755:0.007274:0.012411:0.017857:0.012315:0.006331:0.003656:0.017857:0.012315:0.007274:0.007755:0.012257:0.005600:0.003656:0.012931:0.012931:0.003656:0.003656:0.011545:0.012758:0.007755:0.007274:0.010122:0.017857:0.012931:0.006331:0.012411:0.017857:0.007274:0.007755:0.005519:0.012315:0.007274:0.011507:0.003656:0.006331:0.007468:0.005330
in a significant increase in quality of life and :@0.084242:0.771143:0.480465:0.771143:0.480465:0.755387:0.084242:0.755387:0.003656:0.011545:0.004497:0.012950:0.004499:0.007274:0.003656:0.012758:0.011545:0.003656:0.004589:0.004589:0.012257:0.012950:0.011545:0.006331:0.004497:0.003656:0.011545:0.012257:0.005519:0.012315:0.012950:0.007274:0.012315:0.004499:0.003656:0.011545:0.004499:0.012931:0.011507:0.012950:0.003656:0.003656:0.006331:0.010122:0.004499:0.012411:0.005850:0.004499:0.003656:0.003656:0.005850:0.012315:0.004499:0.012950:0.011545:0.013183:0.005330
more efficient treatment cycles. Dehydra-:@0.084242:0.787508:0.475173:0.787508:0.475173:0.771752:0.084242:0.771752:0.017857:0.012411:0.005519:0.012315:0.007208:0.012315:0.005850:0.004589:0.004589:0.012257:0.003656:0.012315:0.011545:0.006331:0.007208:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.007208:0.012257:0.010122:0.012257:0.003656:0.012315:0.007274:0.005138:0.007208:0.014124:0.012315:0.011545:0.010122:0.012989:0.005600:0.012950:0.006388
tion may occur when patients do not eat :@0.084242:0.803872:0.480505:0.803872:0.480505:0.788116:0.084242:0.788116:0.006331:0.003656:0.012411:0.011545:0.007147:0.017857:0.012950:0.010122:0.007145:0.012411:0.012257:0.012257:0.011507:0.005600:0.007147:0.015798:0.011545:0.012315:0.011545:0.007145:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.007145:0.012989:0.012411:0.007145:0.011545:0.012411:0.006331:0.007145:0.012315:0.012950:0.006521:0.005330
or drink enough, due to poor CINV control :@0.084242:0.820237:0.480561:0.820237:0.480561:0.804481:0.084242:0.804481:0.012411:0.005600:0.006042:0.012989:0.005600:0.003656:0.011545:0.009467:0.006042:0.012315:0.011545:0.012411:0.011507:0.012758:0.011545:0.005138:0.006042:0.012989:0.011507:0.012315:0.006042:0.006331:0.012411:0.006042:0.012931:0.012411:0.012411:0.005600:0.006042:0.015452:0.004156:0.014047:0.013316:0.006042:0.012257:0.012411:0.011545:0.006331:0.005521:0.012411:0.003852:0.005330
and gastro-intestinal damage. Poor CINV :@0.084242:0.836601:0.480520:0.836601:0.480520:0.820845:0.084242:0.820845:0.012950:0.011545:0.012989:0.008755:0.012758:0.012950:0.007274:0.006331:0.005521:0.012411:0.006196:0.003656:0.011545:0.006331:0.012315:0.007274:0.006331:0.003656:0.011545:0.012950:0.003656:0.008755:0.012989:0.012950:0.017857:0.012950:0.012758:0.012315:0.005138:0.008755:0.011199:0.012411:0.012411:0.005600:0.008755:0.015452:0.004156:0.014047:0.013510:0.005330
control may compromise overall antican-:@0.084242:0.852965:0.475175:0.852965:0.475175:0.837210:0.084242:0.837210:0.012257:0.012411:0.011545:0.006331:0.005519:0.012411:0.003656:0.008178:0.017857:0.012950:0.010122:0.008178:0.012257:0.012411:0.017857:0.012931:0.005521:0.012411:0.017857:0.003656:0.007274:0.012315:0.008168:0.012411:0.010468:0.012315:0.005600:0.012950:0.003656:0.003656:0.008178:0.012950:0.011545:0.006331:0.003656:0.012257:0.012950:0.011545:0.006388
cer treatment outcome.:@0.084242:0.869330:0.306606:0.869330:0.306606:0.853574:0.084242:0.853574:0.012257:0.012315:0.005600:0.005138:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005138:0.012411:0.011507:0.006331:0.012257:0.012411:0.017857:0.012315:0.005330
25-30:@0.306370:0.863699:0.334506:0.863699:0.334506:0.854513:0.306370:0.854513:0.006103:0.006103:0.003612:0.006103:0.006215
GASTRO-INTESTINAL SIDE EFFECTS:@0.084242:0.902369:0.421198:0.902369:0.421198:0.884554:0.084242:0.884554:0.017960:0.015822:0.011118:0.008980:0.012401:0.017960:0.008980:0.005987:0.015822:0.008980:0.011118:0.011118:0.008980:0.005987:0.015822:0.015822:0.009407:0.005987:0.011118:0.005987:0.014966:0.011118:0.005987:0.011118:0.010263:0.010263:0.011118:0.016677:0.008980:0.011118
Mucositis, diarrhoea, abdominal cramps, :@0.084242:0.919880:0.480476:0.919880:0.480476:0.904124:0.084242:0.904124:0.017684:0.011699:0.012450:0.012604:0.007466:0.003848:0.006523:0.003848:0.007466:0.005330:0.008775:0.013181:0.003848:0.013143:0.005792:0.006344:0.011738:0.012604:0.012508:0.013143:0.005330:0.008775:0.013143:0.013123:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.003848:0.008775:0.012450:0.005792:0.013143:0.018049:0.013123:0.007466:0.005330:0.005330
and constipation are common side effects :@0.084242:0.936244:0.480505:0.936244:0.480505:0.920488:0.084242:0.920488:0.013143:0.011738:0.013181:0.003964:0.012450:0.012604:0.011738:0.007466:0.006523:0.003848:0.013123:0.013143:0.006523:0.003848:0.012604:0.011738:0.003964:0.013143:0.005715:0.012508:0.003964:0.012450:0.012604:0.018049:0.018049:0.012604:0.011726:0.003964:0.007466:0.003848:0.013181:0.012508:0.003964:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330
of chemotherapeutic treatments that kill :@0.523643:0.096166:0.919884:0.096166:0.919884:0.080410:0.523643:0.080410:0.012604:0.006042:0.008813:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013129:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.008813:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.008813:0.006523:0.011738:0.013143:0.006523:0.008813:0.009660:0.003848:0.003848:0.003848:0.005330
rapidly-dividing cells.:@0.523643:0.112517:0.717318:0.112517:0.717318:0.096761:0.523643:0.096761:0.005792:0.013143:0.013123:0.003848:0.013181:0.003848:0.010314:0.006388:0.013181:0.003848:0.010660:0.003848:0.013181:0.003848:0.011738:0.012950:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
31:@0.717338:0.106903:0.729768:0.106903:0.729768:0.097718:0.717338:0.097718:0.006215:0.006215
FATIGUE:@0.523636:0.145560:0.607447:0.145560:0.607447:0.127744:0.523636:0.127744:0.010263:0.015822:0.008980:0.005987:0.017960:0.013683:0.011118
Fatigue may be related to cancer or anti- :@0.523636:0.163063:0.919879:0.163063:0.919879:0.147307:0.523636:0.147307:0.009333:0.013143:0.006523:0.003848:0.012950:0.011699:0.012508:0.005582:0.018049:0.013143:0.010314:0.005600:0.013123:0.012508:0.005590:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005590:0.006523:0.012604:0.005582:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005580:0.012604:0.005792:0.005582:0.013143:0.011738:0.006523:0.003848:0.006388:0.005330
cancer treatment. Fatigue may last  for :@0.523636:0.179414:0.919881:0.179414:0.919881:0.163658:0.523636:0.163658:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011468:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.011468:0.009333:0.013143:0.006523:0.003848:0.012950:0.011699:0.012508:0.011468:0.018049:0.013143:0.010314:0.011468:0.003848:0.013143:0.007466:0.006523:0.005330:0.006150:0.006042:0.012604:0.005792:0.005330
months following treatment. Anaemia is a :@0.523636:0.195765:0.919862:0.195765:0.919862:0.180009:0.523636:0.180009:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005927:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005927:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005917:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005927:0.003848:0.007466:0.005927:0.013143:0.005330
cause of fatigue which is usually multifac-:@0.523636:0.212117:0.914526:0.212117:0.914526:0.196361:0.523636:0.196361:0.012450:0.013143:0.011699:0.007466:0.012508:0.006196:0.012604:0.006042:0.006196:0.006042:0.013143:0.006523:0.003848:0.012950:0.011699:0.012508:0.006196:0.015990:0.011738:0.003848:0.012450:0.011738:0.006196:0.003848:0.007466:0.006196:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.006196:0.018049:0.011699:0.003848:0.006523:0.003848:0.006042:0.013143:0.012450:0.006388
torial and can be caused by chemother-:@0.523636:0.228468:0.914545:0.228468:0.914545:0.212712:0.523636:0.212712:0.006523:0.012604:0.005792:0.003848:0.013143:0.003848:0.006658:0.013143:0.011738:0.013181:0.006658:0.012450:0.013143:0.011738:0.006658:0.013123:0.012508:0.006658:0.012450:0.013143:0.011699:0.007466:0.012508:0.013181:0.006658:0.013123:0.010314:0.006658:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.006388
apy, surgery, radiotherapy, primary, meta-:@0.523636:0.244819:0.914541:0.244819:0.914541:0.229063:0.523636:0.229063:0.013143:0.013123:0.010314:0.005330:0.004522:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.005330:0.004522:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.004522:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.005330:0.004522:0.018049:0.012508:0.006523:0.013143:0.006388
static disease or nutritional depletion. :@0.523636:0.261170:0.875272:0.261170:0.875272:0.245414:0.523636:0.245414:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.012604:0.005792:0.005330:0.011738:0.011699:0.006523:0.005792:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.013181:0.012508:0.013123:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
23-32:@0.875251:0.255585:0.903836:0.255585:0.903836:0.246399:0.875251:0.246399:0.006215:0.006215:0.003724:0.006215:0.006215
ALOPECIA:@0.523636:0.294241:0.628400:0.294241:0.628400:0.276426:0.523636:0.276426:0.015822:0.009407:0.017960:0.011973:0.011118:0.016677:0.005987:0.015822
Alopecia can be caused by chemothera-:@0.523636:0.311744:0.914545:0.311744:0.914545:0.295988:0.523636:0.295988:0.014239:0.003848:0.012604:0.013123:0.012508:0.012450:0.003848:0.013143:0.004974:0.012450:0.013143:0.011738:0.004974:0.013123:0.012508:0.004974:0.012450:0.013143:0.011699:0.007466:0.012508:0.013181:0.004984:0.013123:0.010314:0.004984:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013114:0.006388
py agents that kill hair follicles and can be :@0.523636:0.328096:0.919883:0.328096:0.919883:0.312340:0.523636:0.312340:0.013123:0.010314:0.005253:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005253:0.006523:0.011738:0.013143:0.006523:0.005242:0.009660:0.003848:0.003848:0.003848:0.005253:0.011738:0.013143:0.003848:0.005792:0.005253:0.006042:0.012604:0.003848:0.003848:0.003848:0.012450:0.003848:0.012508:0.007466:0.005253:0.013143:0.011738:0.013181:0.005253:0.012450:0.013143:0.011738:0.005253:0.013123:0.012508:0.005330
complete or partial. These are most often :@0.523636:0.344447:0.919893:0.344447:0.919893:0.328691:0.523636:0.328691:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.006388:0.012604:0.005792:0.006388:0.013123:0.013143:0.005792:0.006523:0.003848:0.013143:0.003848:0.005330:0.006388:0.008197:0.011738:0.012508:0.007466:0.012508:0.006388:0.013143:0.005713:0.012508:0.006388:0.018049:0.012604:0.007466:0.006523:0.006388:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330
temporary  side  effects:  Hair  usually starts :@0.523636:0.360798:0.919868:0.360798:0.919868:0.345042:0.523636:0.345042:0.006523:0.012508:0.018049:0.013123:0.012604:0.005792:0.013143:0.005792:0.010314:0.005330:0.003113:0.007466:0.003848:0.013181:0.012508:0.005330:0.003123:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005330:0.003121:0.013143:0.013143:0.003848:0.005792:0.005330:0.003127:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.008467:0.007466:0.006523:0.013143:0.005792:0.006523:0.007466:0.005330
to  regrow during or  a few weeks after :@0.523636:0.377149:0.919902:0.377149:0.919902:0.361393:0.523636:0.361393:0.006523:0.012604:0.005330:0.005936:0.005713:0.012508:0.012950:0.005707:0.012604:0.015990:0.011276:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.011276:0.012604:0.005792:0.005330:0.005934:0.013143:0.011276:0.006042:0.012508:0.015990:0.011276:0.015990:0.012508:0.012508:0.009660:0.007466:0.011276:0.013143:0.006042:0.006523:0.012508:0.005792:0.005330
treatment  completion.  It  can  be associ-:@0.523636:0.393501:0.914547:0.393501:0.914547:0.377745:0.523636:0.377745:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004235:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.004239:0.004349:0.006523:0.005330:0.004243:0.012450:0.013143:0.011738:0.005330:0.004243:0.013123:0.012508:0.009583:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.006388
ated with change of colour, texture, thick-:@0.523636:0.409852:0.914565:0.409852:0.914565:0.394096:0.523636:0.394096:0.013143:0.006523:0.012508:0.013181:0.005234:0.015990:0.003848:0.006523:0.011738:0.005224:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.005224:0.012604:0.006042:0.005224:0.012450:0.012604:0.003848:0.012604:0.011699:0.003760:0.005330:0.005234:0.006523:0.012508:0.009236:0.006523:0.011699:0.005707:0.012508:0.005330:0.005224:0.006523:0.011738:0.003848:0.012450:0.009660:0.006388
ness, and style. Severe alopecia occurs :@0.523636:0.426203:0.919895:0.426203:0.919895:0.410447:0.523636:0.410447:0.011738:0.012508:0.007466:0.007466:0.005330:0.010352:0.013143:0.011738:0.013181:0.010352:0.007466:0.006523:0.010314:0.003848:0.012508:0.005330:0.010352:0.009583:0.012508:0.010660:0.012508:0.005715:0.012508:0.010352:0.013143:0.003848:0.012604:0.013123:0.012508:0.012450:0.003848:0.013143:0.010352:0.012604:0.012450:0.012450:0.011699:0.005792:0.007466:0.005330
most frequently with drugs such as doxo-:@0.523636:0.442554:0.914570:0.442554:0.914570:0.426798:0.523636:0.426798:0.018049:0.012604:0.007466:0.006523:0.007512:0.006042:0.005713:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.003848:0.010314:0.007524:0.015990:0.003848:0.006523:0.011738:0.007524:0.013181:0.005792:0.011699:0.012950:0.007466:0.007514:0.007466:0.011699:0.012450:0.011738:0.007514:0.013143:0.007466:0.007524:0.013181:0.012604:0.009236:0.012604:0.006388
rubicin, daunorubicin, paclitaxel, doc-:@0.523636:0.458906:0.914545:0.458906:0.914545:0.443150:0.523636:0.443150:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.005330:0.017087:0.013181:0.013143:0.011699:0.011738:0.012604:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.005330:0.017087:0.013123:0.013143:0.012450:0.003848:0.003848:0.006523:0.013143:0.009236:0.012508:0.003848:0.005330:0.017087:0.013181:0.012604:0.012450:0.006388
etaxel, cyclophosphamide, ifosfamide or :@0.523636:0.475257:0.919875:0.475257:0.919875:0.459501:0.523636:0.459501:0.012508:0.006523:0.013143:0.009236:0.012508:0.003848:0.005330:0.008390:0.012450:0.010314:0.012450:0.003848:0.012604:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.018049:0.003848:0.013181:0.012508:0.005330:0.008390:0.003848:0.006042:0.012604:0.007466:0.006042:0.013143:0.018049:0.003848:0.013181:0.012508:0.008390:0.012604:0.005792:0.005330
etoposide.  Permanent alopecia can oc-:@0.523636:0.491608:0.914551:0.491608:0.914551:0.475852:0.523636:0.475852:0.012508:0.006523:0.012604:0.013123:0.012604:0.007466:0.003848:0.013181:0.012508:0.005330:0.006773:0.006773:0.011392:0.012508:0.006317:0.018049:0.013143:0.011738:0.012508:0.011738:0.006523:0.006773:0.013143:0.003848:0.012604:0.013123:0.012508:0.012450:0.003848:0.013143:0.006773:0.012450:0.013143:0.011738:0.006773:0.012604:0.012450:0.006388
cur, but is  not common.  Chemotherapy :@0.523636:0.507959:0.919891:0.507959:0.919891:0.492203:0.523636:0.492203:0.012450:0.011699:0.003766:0.005330:0.009929:0.013123:0.011699:0.006523:0.009929:0.003848:0.007466:0.005330:0.004610:0.011738:0.012604:0.006523:0.009929:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.005330:0.004589:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
induces alopecia  in women more often :@0.523636:0.524311:0.919879:0.524311:0.919879:0.508555:0.523636:0.508555:0.003848:0.011738:0.013181:0.011699:0.012450:0.012508:0.007466:0.009717:0.013143:0.003848:0.012604:0.013123:0.012508:0.012450:0.003848:0.013143:0.005330:0.004399:0.003848:0.011738:0.009717:0.015990:0.012604:0.018049:0.012508:0.011738:0.009717:0.018049:0.012604:0.005707:0.012508:0.009717:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330
than men.:@0.523636:0.540662:0.619732:0.540662:0.619732:0.524906:0.523636:0.524906:0.006523:0.011738:0.013143:0.011738:0.005330:0.018049:0.012508:0.011738:0.005330
33:@0.619716:0.535121:0.632146:0.535121:0.632146:0.525935:0.619716:0.525935:0.006215:0.006215
SECONDARY NEOPLASM:@0.523636:0.573777:0.771221:0.573777:0.771221:0.555962:0.523636:0.555962:0.011118:0.011118:0.016677:0.017960:0.015822:0.014966:0.015822:0.012401:0.013256:0.005987:0.015822:0.011118:0.017960:0.011973:0.009407:0.015822:0.011118:0.019242
Development of  secondary neoplasia :@0.523636:0.591280:0.919883:0.591280:0.919883:0.575524:0.523636:0.575524:0.014316:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.018049:0.012508:0.011738:0.006523:0.017761:0.012604:0.006042:0.005330:0.012419:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.017761:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.003848:0.013143:0.005330
following completion of chemotherapy :@0.523636:0.607632:0.919914:0.607632:0.919914:0.591876:0.523636:0.591876:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.013681:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.013681:0.012604:0.006042:0.013681:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
or  radiotherapy  treatment  can  occur. :@0.523636:0.623983:0.919874:0.623983:0.919874:0.608227:0.523636:0.608227:0.012604:0.005792:0.005330:0.010004:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013112:0.010314:0.005330:0.010016:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.010002:0.012450:0.013143:0.011738:0.005330:0.010012:0.012604:0.012450:0.012450:0.011699:0.004372:0.005330:0.005330
Secondary acute myeloid leukaemia is :@0.523636:0.640334:0.919856:0.640334:0.919856:0.624578:0.523636:0.624578:0.009583:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.012296:0.013143:0.012450:0.011699:0.006523:0.012508:0.012296:0.018049:0.010314:0.012508:0.003848:0.012604:0.003848:0.013181:0.012296:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.012296:0.003848:0.007466:0.005330
the most common secondary neoplasm, :@0.523636:0.656685:0.919895:0.656685:0.919895:0.640929:0.523636:0.640929:0.006523:0.011738:0.012508:0.008255:0.018049:0.012604:0.007466:0.006523:0.008255:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.008255:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.008255:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.005330:0.005330
which appears mainly after treatment with :@0.523636:0.673037:0.919868:0.673037:0.919868:0.657281:0.523636:0.657281:0.015990:0.011738:0.003848:0.012450:0.011738:0.004118:0.013143:0.013123:0.013123:0.012508:0.013143:0.005792:0.007466:0.004118:0.018049:0.013143:0.003848:0.011738:0.003848:0.010314:0.004118:0.013143:0.006042:0.006523:0.012508:0.005792:0.004108:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.004106:0.015990:0.003848:0.006523:0.011738:0.005330
alkylating  agents (cyclophosphamide :@0.523636:0.689388:0.919868:0.689388:0.919868:0.673632:0.523636:0.673632:0.013143:0.003848:0.009660:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.018811:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.024130:0.007100:0.012450:0.010314:0.012450:0.003848:0.012604:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.018049:0.003848:0.013181:0.012508:0.005330
and others) or topoisomerase inhibitors :@0.523636:0.705739:0.919866:0.705739:0.919866:0.689983:0.523636:0.689983:0.013143:0.011738:0.013181:0.012989:0.012604:0.006523:0.011738:0.012508:0.005792:0.007466:0.007100:0.012989:0.012604:0.005792:0.012989:0.006523:0.012604:0.013123:0.012604:0.003848:0.007466:0.012604:0.018049:0.012508:0.005792:0.013133:0.007466:0.012508:0.012989:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466:0.005330
(etoposide).  It has been noted that long-:@0.523636:0.722090:0.914556:0.722135:0.914556:0.706379:0.523636:0.706334:0.007100:0.012508:0.006523:0.012604:0.013123:0.012604:0.007466:0.003848:0.013181:0.012508:0.007100:0.005330:0.012433:0.004916:0.004349:0.006523:0.004915:0.011738:0.013143:0.007466:0.004926:0.013123:0.012508:0.012508:0.011738:0.004913:0.011738:0.012604:0.006523:0.012508:0.013181:0.004907:0.006523:0.011738:0.013143:0.006523:0.004911:0.003848:0.012604:0.011738:0.012950:-0.481083
34:@0.637531:0.716516:0.649961:0.716516:0.649961:0.707330:0.637531:0.707330:0.006215:0.006215
term survivors of childhood malignancies :@0.523638:0.738486:0.919867:0.738486:0.919867:0.722730:0.523638:0.722730:0.006523:0.012508:0.006319:0.018049:0.008236:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.012604:0.005792:0.007466:0.008236:0.012604:0.006042:0.008236:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.008236:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330
have a 13 times higher risk of developing :@0.523638:0.754838:0.919849:0.754838:0.919849:0.739082:0.523638:0.739082:0.011738:0.013143:0.010660:0.012508:0.007004:0.013143:0.007004:0.010660:0.010660:0.007004:0.006523:0.003848:0.018049:0.012508:0.007466:0.007004:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792:0.006995:0.005792:0.003848:0.007466:0.009660:0.007004:0.012604:0.006042:0.007004:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.003848:0.011738:0.012950:0.005330
secondary neoplasms during the 30 years :@0.523638:0.771189:0.919876:0.771189:0.919876:0.755433:0.523638:0.755433:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.006254:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.007466:0.006254:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.006244:0.006523:0.011738:0.012508:0.006242:0.010660:0.010660:0.006254:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
after treatment compared to the general :@0.523638:0.787540:0.919897:0.787540:0.919897:0.771784:0.523638:0.771784:0.013143:0.006042:0.006523:0.012508:0.005792:0.006106:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006106:0.012450:0.012604:0.018049:0.013123:0.013143:0.005713:0.012508:0.013181:0.006119:0.006523:0.012604:0.006106:0.006523:0.011738:0.012508:0.006108:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330
population.:@0.523638:0.803891:0.631223:0.803891:0.631223:0.788135:0.523638:0.788135:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
35:@0.631217:0.798300:0.643647:0.798300:0.643647:0.789115:0.631217:0.789115:0.006215:0.006215
INFERTILITY:@0.523636:0.836956:0.631821:0.836956:0.631821:0.819141:0.523636:0.819141:0.005987:0.015822:0.010263:0.011118:0.012401:0.008980:0.005987:0.009407:0.005987:0.008980:0.013256
Some chemotherapy agents are toxic to :@0.523636:0.854460:0.919881:0.854460:0.919881:0.838704:0.523636:0.838704:0.009583:0.012604:0.018049:0.012508:0.007641:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011722:0.012508:0.005792:0.013143:0.013123:0.010314:0.007649:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.007641:0.013143:0.005715:0.012508:0.007643:0.006523:0.012604:0.009236:0.003848:0.012450:0.007643:0.006523:0.012604:0.005330
the  gonads and may cause infertility.   :@0.523636:0.870811:0.919875:0.870816:0.919875:0.855061:0.523636:0.855055:0.006523:0.011738:0.012508:0.005330:0.006589:0.012950:0.012604:0.011738:0.013143:0.013181:0.007466:0.011930:0.013143:0.011738:0.013181:0.011930:0.018049:0.013143:0.010314:0.011930:0.012450:0.013143:0.011699:0.007466:0.012508:0.011930:0.003848:0.011738:0.006042:0.012508:0.005792:0.006523:0.003848:0.003848:0.003848:0.006523:0.010314:0.005330:0.012422:0.000000:-0.703724
36:@0.902110:0.865197:0.914540:0.865197:0.914540:0.856012:0.902110:0.856012:0.006215:0.006215
Drugs with high risk include procarbazine :@0.523635:0.887168:0.919894:0.887168:0.919894:0.871412:0.523635:0.871412:0.014316:0.005792:0.011699:0.012950:0.007466:0.007782:0.015990:0.003848:0.006523:0.011738:0.007782:0.011738:0.003848:0.012950:0.011738:0.007780:0.005792:0.003848:0.007466:0.009660:0.007793:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007793:0.013123:0.005713:0.012604:0.012450:0.013143:0.005792:0.013123:0.013143:0.008178:0.003848:0.011738:0.012508:0.005330
and other alkylating agents, including cy-:@0.523635:0.903519:0.914550:0.903519:0.914550:0.887763:0.523635:0.887763:0.013143:0.011738:0.013181:0.006119:0.012604:0.006523:0.011728:0.012508:0.005792:0.006108:0.013143:0.003848:0.009660:0.010314:0.003860:0.013143:0.006523:0.003848:0.011738:0.012950:0.006109:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.006106:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.006119:0.012450:0.010314:0.006388
clophosphamide,  ifosfamide,  busulfan, :@0.523635:0.919870:0.919863:0.919870:0.919863:0.904114:0.523635:0.904114:0.012450:0.003848:0.012604:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.018049:0.003848:0.013181:0.012508:0.005330:0.005330:0.014668:0.003848:0.006042:0.012604:0.007466:0.006042:0.013143:0.018049:0.003848:0.013181:0.012508:0.005330:0.005330:0.014665:0.013123:0.011699:0.007466:0.011699:0.003848:0.006042:0.013143:0.011738:0.005330:0.005330
melphalan and chlorambucil.  Agents :@0.523635:0.936221:0.919892:0.936244:0.919892:0.920488:0.523635:0.920466:0.018049:0.012508:0.003848:0.013123:0.011738:0.013143:0.003848:0.013143:0.011738:0.015317:0.013143:0.011738:0.013181:0.015317:0.012450:0.011738:0.003848:0.012604:0.005792:0.013143:0.018049:0.013123:0.011699:0.012450:0.003848:0.003848:0.005330:0.012429:0.015317:0.014239:0.012950:0.012508:0.011738:0.006523:0.007466:-0.798908
37:@0.821387:0.930625:0.833817:0.930625:0.833817:0.921439:0.821387:0.921439:0.006215:0.006215